Renal and cardiovascular effects of SGLT2 inhibitors among hypertensive patients with chronic kidney disease: A systematic review and meta-analysis.

Javier RM, Faizin I, Andiani, Samudra D, Puspitasari RA, Dharma AS, Nurpradika BY, Amalia F, Danny SS, Kuncoro BAS, Pintaningrum Y, Firasghani MA, Fiohana P, Kosen YD, Kurniawan K.

Open source

DOI: 10.1016/j.ijcrp.2026.200585
Published: 2026-01-29
Container: Int J Cardiol Cardiovasc Risk Prev
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijcrp.2026.200585,
  title = {Renal and cardiovascular effects of SGLT2 inhibitors among hypertensive patients with chronic kidney disease: A systematic review and meta-analysis.},
  author = {Javier RM and  Faizin I and  Andiani and  Samudra D and  Puspitasari RA and  Dharma AS and  Nurpradika BY and  Amalia F and  Danny SS and  Kuncoro BAS and  Pintaningrum Y and  Firasghani MA and  Fiohana P and  Kosen YD and  Kurniawan K.},
  year = {2026},
  journal = {Int J Cardiol Cardiovasc Risk Prev},
  doi = {10.1016/j.ijcrp.2026.200585},
  url = {https://doi.org/10.1016/j.ijcrp.2026.200585}
}

RIS

TY  - JOUR
TI  - Renal and cardiovascular effects of SGLT2 inhibitors among hypertensive patients with chronic kidney disease: A systematic review and meta-analysis.
AU  - Javier RM
AU  -  Faizin I
AU  -  Andiani
AU  -  Samudra D
AU  -  Puspitasari RA
AU  -  Dharma AS
AU  -  Nurpradika BY
AU  -  Amalia F
AU  -  Danny SS
AU  -  Kuncoro BAS
AU  -  Pintaningrum Y
AU  -  Firasghani MA
AU  -  Fiohana P
AU  -  Kosen YD
AU  -  Kurniawan K.
PY  - 2026
JO  - Int J Cardiol Cardiovasc Risk Prev
DO  - 10.1016/j.ijcrp.2026.200585
UR  - https://doi.org/10.1016/j.ijcrp.2026.200585
ER  -

APA

RM, J., I, F., Andiani, D, S., RA, P., AS, D., BY, N., F, A., SS, D., BAS, K., Y, P., MA, F., P, F., YD, K., & K., K. (2026). Renal and cardiovascular effects of SGLT2 inhibitors among hypertensive patients with chronic kidney disease: A systematic review and meta-analysis.. Int J Cardiol Cardiovasc Risk Prev. https://doi.org/10.1016/j.ijcrp.2026.200585

Source records

europe-pmc · retrieved 2026-09-27T02:20:14.584Z
doaj · retrieved 2026-09-27T02:20:14.593Z